Bioptimus
Focus: Bioptimus is an AI-driven drug discovery company headquartered in Paris, focusing on ophthalmology and neurology therapeutics. The company operates at small-to-mid scale (51-200 employees) within the biotechnology segment.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Employees
51-200
Open Jobs
2-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Bioptimus?
AI assessmentBioptimus is a high-risk, high-reward opportunity for AI/computational scientists seeking early-stage exposure but offers limited near-term visibility for clinical or commercial roles.
Why Work Here
- Opportunity to build AI drug discovery capabilities from the ground up in an emerging biotech with focused therapeutic areas
- Early-stage company offers potential for outsized equity upside and meaningful individual contribution in shaping company direction
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Bioptimus
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.